Literature DB >> 7730614

Adoptive cell transfer of contact sensitivity-initiation mediated by nonimmune cells sensitized with monoclonal IgE antibodies. Dependence on host skin mast cells.

H Matsuda1, H Ushio, V Paliwal, W Ptak, P W Askenase.   

Abstract

A role for mast cell release of serotonin (5-HT), via Ag-specific factors derived from Thy-1+ B220+ lymphoid cells in the initiation of murine contact sensitivity (CS) has been suggested. However, because CS in mast cell-deficient mice was intact, a role for mast cells in CS initiation was unclear. Therefore, we examined whether CS could be initiated by i.v. injection of nonimmune mixed lymphoid cells that were sensitized in vitro with IgE. When naive mice received IgE-sensitized nonimmune spleen or lymph node cells, or IgE-sensitized purified mast cells, together with immune CS-effector B220- T cells, which therefore were depleted of CS-initiating, Thy-1+, B220+ cells, which could not transfer CS, then reconstitution of CS occurred. Mast cell-deficient W/Wv mice could not elicit this IgE-dependent CS ear swelling, but when mast cell deficiency was reversed by ear injection of normal bone marrow-derived cultured mast cells, then CS was restored. In vitro pretreatment with irrelevant monoclonal anti-OVA IgE prevented CS initiation mediated by Ag-specific, IgE mAb-sensitized cells, presumably by blocking sensitization with IgE. Thus Fc epsilon R on the normal lymphoid cells were involved. When ketanserin, a 5-HT2 receptor antagonist, was injected i.v. before cell transfer, CS initiation via IgE-sensitized cells and CS were no longer elicited. Thus, in this system, IgE Abs bound to circulating IgE Fc epsilon R bearing lymphoid cells sensitized in vitro (most likely basophils), probably mediated early activation of these circulating basophils to release mediators, causing 5-HT release from cutaneous mast cells, to mediate CS initiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730614

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response.

Authors:  M Ursula Norman; John Hwang; Sara Hulliger; Claudine S Bonder; Jun Yamanouchi; Pere Santamaria; Paul Kubes
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

2.  Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine.

Authors:  H Yokozeki; K Watanabe; K Igawa; Y Miyazaki; I Katayama; K Nishioka
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

3.  Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice.

Authors:  H Yokozeki; M-H Wu; K Sumi; K Igawa; Y Miyazaki; I Katayama; K Takeda; S Akira; K Nishioka
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

4.  Mast cell activation and migration to lymph nodes during induction of an immune response in mice.

Authors:  H W Wang; N Tedla; A R Lloyd; D Wakefield; P H McNeil
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

5.  Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans.

Authors:  Zuyi Weng; Bodi Zhang; Shahrzad Asadi; Nikolaos Sismanopoulos; Alan Butcher; Xueyan Fu; Alexandra Katsarou-Katsari; Christina Antoniou; Theoharis C Theoharides
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity.

Authors:  H Yokozeki; M Ghoreishi; S Takagawa; K Takayama; T Satoh; I Katayama; K Takeda; S Akira; K Nishioka
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

7.  A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity.

Authors:  John M Hwang; Jun Yamanouchi; Pere Santamaria; Paul Kubes
Journal:  J Exp Med       Date:  2004-04-26       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.